Ausaf Ahmad1,2, Soumyaroop Bhattacharya1,2, Arthi Sridhar3, Anwar M Iqbal3, Thomas J Mariani1,2. 1. Division of Neonatology, Department of Pediatrics, University of Rochester Medical Center, Rochester, New York. 2. Department of Pediatrics, Pediatric Molecular and Personalized Medicine Program, University of Rochester Medical Center, Rochester, New York. 3. Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, New York.
Abstract
BACKGROUND: Variability in the incidence and severity of bronchopulmonary dysplasia (BPD) among premature infants suggests that genetic susceptibility plays a role in pathogenesis. An assessment of copy number variants (CNV) in BPD subjects may help to identify loci that harbor genetic susceptibility factors. METHODS: We conducted a retrospective analysis of clinical DNA microarray data from our institution. We identified 19 BPD subjects, and 2 controls groups (full-term and preterm) with no lung-related disease. We reanalyzed raw data from each of these subjects to identify recurrent CNV loci in BPD subjects. RESULTS: We identified three loci (at 11q13.2, 16p13.3, and 22q11.23-q12.1) with recurrent CNV in BPD subjects. The frequency of these CNV was significantly higher in BPD subjects when compared with at least one control group. We interrogated 21 genes residing within the recurrent CNV regions for development-associated changes in expression. Fifteen genes demonstrated significant changes in expression between the pseudoglandular and canalicular stage in human lungs, a time commensurate with birth at highest risk for BPD. We also identified pathways represented by the genes present within the recurrent loci. CONCLUSION: These data identify novel loci that may harbor genes contributing to the genetic susceptibility of BPD.
BACKGROUND: Variability in the incidence and severity of bronchopulmonary dysplasia (BPD) among premature infants suggests that genetic susceptibility plays a role in pathogenesis. An assessment of copy number variants (CNV) in BPD subjects may help to identify loci that harbor genetic susceptibility factors. METHODS: We conducted a retrospective analysis of clinical DNA microarray data from our institution. We identified 19 BPD subjects, and 2 controls groups (full-term and preterm) with no lung-related disease. We reanalyzed raw data from each of these subjects to identify recurrent CNV loci in BPD subjects. RESULTS: We identified three loci (at 11q13.2, 16p13.3, and 22q11.23-q12.1) with recurrent CNV in BPD subjects. The frequency of these CNV was significantly higher in BPD subjects when compared with at least one control group. We interrogated 21 genes residing within the recurrent CNV regions for development-associated changes in expression. Fifteen genes demonstrated significant changes in expression between the pseudoglandular and canalicular stage in human lungs, a time commensurate with birth at highest risk for BPD. We also identified pathways represented by the genes present within the recurrent loci. CONCLUSION: These data identify novel loci that may harbor genes contributing to the genetic susceptibility of BPD.
Authors: Hui Wang; Krystal R St Julien; David K Stevenson; Thomas J Hoffmann; John S Witte; Laura C Lazzeroni; Mark A Krasnow; Cecele C Quaintance; John W Oehlert; Laura L Jelliffe-Pawlowski; Jeffrey B Gould; Gary M Shaw; Hugh M O'Brodovich Journal: Pediatrics Date: 2013-07-29 Impact factor: 7.124
Authors: Iveta Sarova; Jana Brezinova; Zuzana Zemanova; Dagmar Bystricka; Zdenek Krejcik; Petr Soukup; Jan Vydra; Jaroslav Cermak; Anna Jonasova; Kyra Michalova Journal: Genes Chromosomes Cancer Date: 2013-04-12 Impact factor: 5.006
Authors: Thomas J Hoffmann; Gary M Shaw; David K Stevenson; Hui Wang; Cecele C Quaintance; John Oehlert; Laura L Jelliffe-Pawlowski; Jeffrey B Gould; John S Witte; Hugh M O'Brodovich Journal: Am J Med Genet A Date: 2014-06-26 Impact factor: 2.802
Authors: Philip E Stuart; Ulrike Hüffmeier; Rajan P Nair; Raquel Palla; Trilokraj Tejasvi; Joost Schalkwijk; James T Elder; Andre Reis; John A L Armour Journal: J Invest Dermatol Date: 2012-06-28 Impact factor: 8.551
Authors: Amrit Kumar Shrestha; Matthew L Bettini; Renuka T Menon; Vashisht Y N Gopal; Shixia Huang; Dean P Edwards; Mohan Pammi; Roberto Barrios; Binoy Shivanna Journal: Am J Physiol Lung Cell Mol Physiol Date: 2018-10-11 Impact factor: 5.464
Authors: Oscar A Nyangiri; Harry Noyes; Julius Mulindwa; Hamidou Ilboudo; Justin Windingoudi Kabore; Bernardin Ahouty; Mathurin Koffi; Olivier Fataki Asina; Dieudonne Mumba; Elvis Ofon; Gustave Simo; Magambo Phillip Kimuda; John Enyaru; Vincent Pius Alibu; Kelita Kamoto; John Chisi; Martin Simuunza; Mamadou Camara; Issa Sidibe; Annette MacLeod; Bruno Bucheton; Neil Hall; Christiane Hertz-Fowler; Enock Matovu Journal: BMC Genomics Date: 2020-04-10 Impact factor: 3.969